AstraZeneca UK Ltd and International Fire Consultants (IFC)

Pharmaceutical giant AstraZeneca UK Ltd has filed a £32 million High Court claim against International Fire Consultants (IFC), a Cheltenham-based fire engineering consultancy, over alleged “widespread defects” in fire safety systems at its Discovery Centre headquarters in Cambridge, UK. The dispute centres on the consultancy’s alleged failure to properly perform fire-safety duties during construction, leading to costly remediation works that AstraZeneca says it has already incurred. Project Background

• The Discovery Centre forms part of AstraZeneca’s major headquarters and R&D facilities on the Cambridge Biomedical Campus.
• Originally intended for phased completion earlier in the decade, the project was expanded and delayed, with final completion reported in 2021 after multiple postponements.
• AstraZeneca contracted IFC to advise on fire safety under the supervision of construction manager Skanska (later succeeded by Mace).

Allegations and Causes of Loss

• AstraZeneca claims that IFC failed to identify fundamental fire safety issues in key components of the building, including:
• fire dampers, smoke dampers,
• insulation, and
• ductwork systems,
• which later proved defective once installed.

Although some issues were identified by IFC during a 2021 re-inspection, the company alleges these should have been spotted earlier in the preliminary stages, thereby preventing costly remedial work.
Remediation Costs and Financial Impact

• AstraZeneca asserts that between 2021 and 2023, its remediation costs alone exceeded £31.7 million — nearly the total amount now claimed in damages.

These costs stem from extensive corrective work required to bring fire safety systems up to acceptable standards and to address risks that AstraZeneca alleges IFC failed to manage effectively earlier in the construction process.
Defendant’s Response

• In response, IFC has denied liability, filing a defence that labels AstraZeneca’s claim as “misconceived and incorrect,” with the consultancy hinting that responsibility for latent defects may rest elsewhere, including in prior settlements with construction manager Skanska.

Broader Context

• The claim highlights a major corporate dispute in a sector where fire safety compliance remains at the forefront of regulatory enforcement following the Grenfell Tower fire and subsequent building safety reforms.
• It also illustrates how complex multi-party contractual relationships during large developments — involving contractors, specialist consultants, and project managers — can lead to significant financial exposure when safety systems fail or are inadequately specified.

ConclusionAstraZeneca’s £32 million lawsuit against IFC over alleged fire safety defects at its Cambridge Discovery Centre marks a high-profile example of measurable financial impact driven by regulatory compliance failures and professional negligence in building safety engineering. The case is ongoing, and its outcome could influence how organisations allocate liability for fire safety design and oversight on major developments.